Streetbeat News

Partnerships

AEVA

BTOG

NCNA

PIXY

SURG

SurgePays, Inc. (NASDAQ:SURG) shares fell by approximately 15% in pre-market trading due to worse-than-expected Q4 financial results. Other stocks also showed significant movement in pre-market trading, with notable gainers including NuCana plc (NASDAQ:NCNA) and ShiftPixy, Inc. (NASDAQ:PIXY), and losers like Aeva Technologies, Inc. (NASDAQ:AEVA) and Bit Origin Ltd (NASDAQ:BTOG).

Portfolio Pulse from Avi Kapoor

March 13, 2024 | 12:24 pm

BGNE

The Max Foundation, BeiGene, and the BeiGene Foundation have initiated the distribution of BRUKINSA, a treatment for Chronic Lymphocytic Leukemia, to patients in low- and middle-income countries, starting with Armenia and Nepal. This effort is part of a collaboration aimed at improving access to this critical medication in 29 countries.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 12:08 pm

IMNN

IMUNON, Inc. (NASDAQ:IMNN) has filed an IND application with the FDA for IMNN-101, a DNA-based vaccine for COVID-19, with Phase 1 human trials expected to start in Q2 2024. The vaccine utilizes IMUNON's proprietary PlaCCine platform and aims to demonstrate superior durability and immune response compared to mRNA vaccines. Preclinical data shows promising results, and the company aims to attract partners for further development.

Portfolio Pulse from Happy Mohamed

March 13, 2024 | 12:07 pm

SLDB

Solid Biosciences has entered into a non-exclusive licensing agreement for the use of its proprietary, muscle-targeted AAV-SLB101 capsid.

Portfolio Pulse from Charles Gross

March 13, 2024 | 11:51 am

AGFY

Agrify Corporation (AGFY) has entered into a turnkey extraction equipment deal with Justice Cannabis Co., marking its expansion into the New Jersey market. This partnership signifies Agrify's strategic move to enhance its presence in the rapidly growing cannabis industry by providing state-of-the-art extraction equipment to a leading multi-state operator.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:34 am

DV

DoubleVerify Holdings, Inc. (NYSE:DV) has expanded its collaboration with NBCUniversal to offer program-level measurement solutions for OTT devices, including Connected TV (CTV). This partnership aims to provide NBCUniversal advertisers with tools to assess brand safety, suitability, and content performance at the program level. The company, which has seen a 34% increase in its stock over the last year, expects Q1 revenue of $136 million to $140 million and full-year 2024 revenue of $688 million to $704 million, marking a 22% increase at the midpoint. Macquarie analyst Tim Nollen upgraded DoubleVerify from Neutral to Outperform with a $40 price target.

Portfolio Pulse from Nabaparna Bhattacharya

March 13, 2024 | 11:33 am

AGFY

Agrify Corporation (NASDAQ:AGFY), a leader in cultivation and extraction solutions for the cannabis industry, has announced a deal with Justice Cannabis Co. to provide a comprehensive hydrocarbon extraction and lab equipment package as Justice Cannabis expands into the New Jersey market. This package includes a variety of extraction and lab equipment, as well as a UL-Compliant C1D1 Explosion Proof Room, designed for safe and easy installation.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:32 am

NVDA

ORCL

U.S. markets closed higher with the S&P 500 hitting a record high, driven by Oracle's rally and positive consumer price data. Oracle announced a collaboration with Nvidia, boosting their shares. Asian markets saw mixed results, while European markets and commodities, especially crude oil, traded higher. Economic data showed a rise in inflation to 3.2% year-over-year in February 2024.

Portfolio Pulse from Akanksha Bakshi

March 13, 2024 | 11:22 am

MSFT

TSLA

Elon Musk, CEO of Tesla Inc, mocked OpenAI's logo on X, suggesting it spells 'LIE', which led to backlash from users who criticized Tesla's Full Self Driving feature. Musk's contentious relationship with OpenAI, a company he co-founded and left, has been highlighted by a lawsuit he filed against them, accusing them of betraying founding principles. OpenAI, supported by Microsoft Corporation, refuted Musk's claims, stating there's no founding agreement as Musk suggested.

Portfolio Pulse from Ananya Gairola

March 13, 2024 | 11:14 am

BCDA

BioCardia has entered into a long-term partnership with StemCardia to advance the latter's investigational pluripotent stem cell product candidate for treating heart failure. BioCardia will be the exclusive biotherapeutic delivery partner throughout the FDA approval process for an investigational new drug application (IND) and the expected Phase I/II clinical trials.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:14 am